Novo Raises 2026 Outlook for Third Time as Wegovy Pill Beats Forecasts
Strong Wegovy pill sales helped Novo Nordisk beat forecasts and lift its full-year 2026 sales and profit guidance for the third time.
Already have an account? Sign in.